ExploreWatchlistsPricing
  1. JP-listed companies
  2. Alfresa Holdings Corporation
  3. Financials
  4. Cash from financing

Alfresa Holdings Corporation (2784)

Market cap
¥475.4B
P/E ratio
12.6x
Alfresa Holdings distributes prescription drugs, medical devices, and healthcare products to serve Japan's medical industry through specialized subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 2025-23,534+19.47%
Mar 31, 2024-19,698+52.48%
Mar 31, 2023-12,918-55.69%
Mar 31, 2022-29,151+101.43%
Mar 31, 2021-14,472+14.70%
Mar 31, 2020-12,617-49.25%
Mar 31, 2019-24,860+152.00%
Mar 31, 2018-9,865-16.45%
Mar 31, 2017-11,807-54.58%
Mar 31, 2016-25,996+224.50%
Mar 31, 2015-8,011

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat